UY39308A - Derivados de aminopirimidinilo - Google Patents
Derivados de aminopirimidiniloInfo
- Publication number
- UY39308A UY39308A UY0001039308A UY39308A UY39308A UY 39308 A UY39308 A UY 39308A UY 0001039308 A UY0001039308 A UY 0001039308A UY 39308 A UY39308 A UY 39308A UY 39308 A UY39308 A UY 39308A
- Authority
- UY
- Uruguay
- Prior art keywords
- aminopyrimidinyl
- derivatives
- hydroxy
- combinations
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Un compuesto de la Fórmula I, o una sal de este aceptable desde el punto de vista farmacéutico, en donde R1 y R2 son, cada uno independientemente, hidrógeno o hidroxi; en donde R1 y R2 no son ambos hidroxi. También se proporcionan métodos de tratamiento tales como inhibidores de quinasas Janus y composiciones farmacéuticas que contienen los compuestos de la invención y combinaciones de estos con otros agentes terapéuticos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063047606P | 2020-07-02 | 2020-07-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY39308A true UY39308A (es) | 2022-01-31 |
Family
ID=76829589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001039308A UY39308A (es) | 2020-07-02 | 2021-07-01 | Derivados de aminopirimidinilo |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11655252B2 (es) |
| EP (1) | EP4175959A1 (es) |
| JP (1) | JP2023531992A (es) |
| KR (1) | KR20230018459A (es) |
| CN (1) | CN115996930A (es) |
| AR (1) | AR122860A1 (es) |
| AU (1) | AU2021301417B2 (es) |
| BR (1) | BR112022024929A2 (es) |
| CA (1) | CA3190243A1 (es) |
| IL (1) | IL299603A (es) |
| MX (1) | MX2022015986A (es) |
| TW (1) | TWI782599B (es) |
| UY (1) | UY39308A (es) |
| WO (1) | WO2022003583A1 (es) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0901786B1 (en) | 1997-08-11 | 2007-06-13 | Pfizer Products Inc. | Solid pharmaceutical dispersions with enhanced bioavailability |
| EP2638018A1 (en) * | 2010-11-09 | 2013-09-18 | Cellzome Limited | Pyridine compounds and aza analogues thereof as tyk2 inhibitors |
| EP2832734A4 (en) * | 2012-03-28 | 2015-08-26 | Takeda Pharmaceutical | HETEROCYCLIC CONNECTION |
| GB201303109D0 (en) * | 2013-02-21 | 2013-04-10 | Domainex Ltd | Novel pyrimidine compounds |
| BR112016016397B1 (pt) * | 2014-01-24 | 2021-06-29 | Bayer Cropscience Aktiengesellschaft | Processo para preparar 1-alquil-3-difluorometil-5- fluoro-1h-pirazol-4-carbaldeídos ou os seus ésteres |
| NO2721710T3 (es) * | 2014-08-21 | 2018-03-31 | ||
| US20210052593A1 (en) * | 2018-03-09 | 2021-02-25 | Children's Hospital Medical Center | Compositions and Methods for the Treatment of Macrophage Activation Syndrome |
| CN112142743A (zh) * | 2019-06-28 | 2020-12-29 | 广州诺诚健华医药科技有限公司 | 杂环类化合物、其制备方法及其在医药学上的应用 |
-
2021
- 2021-06-29 TW TW110123811A patent/TWI782599B/zh active
- 2021-06-30 US US17/363,494 patent/US11655252B2/en active Active
- 2021-06-30 CN CN202180046561.3A patent/CN115996930A/zh active Pending
- 2021-06-30 AU AU2021301417A patent/AU2021301417B2/en active Active
- 2021-06-30 KR KR1020227046012A patent/KR20230018459A/ko unknown
- 2021-06-30 IL IL299603A patent/IL299603A/en unknown
- 2021-06-30 WO PCT/IB2021/055851 patent/WO2022003583A1/en active Application Filing
- 2021-06-30 MX MX2022015986A patent/MX2022015986A/es unknown
- 2021-06-30 BR BR112022024929A patent/BR112022024929A2/pt unknown
- 2021-06-30 JP JP2022579799A patent/JP2023531992A/ja active Pending
- 2021-06-30 EP EP21739446.9A patent/EP4175959A1/en active Pending
- 2021-06-30 CA CA3190243A patent/CA3190243A1/en active Pending
- 2021-07-01 UY UY0001039308A patent/UY39308A/es unknown
- 2021-07-01 AR ARP210101853A patent/AR122860A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US11655252B2 (en) | 2023-05-23 |
| AU2021301417B2 (en) | 2023-09-28 |
| WO2022003583A1 (en) | 2022-01-06 |
| CN115996930A (zh) | 2023-04-21 |
| JP2023531992A (ja) | 2023-07-26 |
| TW202208371A (zh) | 2022-03-01 |
| CA3190243A1 (en) | 2022-01-06 |
| TWI782599B (zh) | 2022-11-01 |
| IL299603A (en) | 2023-03-01 |
| KR20230018459A (ko) | 2023-02-07 |
| AR122860A1 (es) | 2022-10-12 |
| AU2021301417A1 (en) | 2023-01-19 |
| EP4175959A1 (en) | 2023-05-10 |
| US20220002301A1 (en) | 2022-01-06 |
| BR112022024929A2 (pt) | 2023-01-31 |
| MX2022015986A (es) | 2023-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY37133A (es) | Derivados de pirazolo[1,5-a]pirazin-4-ilo | |
| AR120080A1 (es) | Compuestos lipídicos de cola ramificada y composiciones para la administración intracelular de agentes terapéuticos | |
| CO2022008344A2 (es) | Derivados de pirazolilo útiles como agentes anticancerígenos | |
| CO2020000194A2 (es) | Inhibidores de quinasa alk2 que contienen imidazol | |
| PE20230238A1 (es) | Inhibidores de kras g12c | |
| PE20212303A1 (es) | Inhibidores aza-heterobiciclicos de mat2a y metodos de uso en el tratamiento de cancer | |
| NI201700020A (es) | Compuestos de aminopirimidinilo como inhibidores de jak | |
| AR125425A1 (es) | Inhibidores de proteina tirosina fosfatasa y sus metodos de uso | |
| CO2022008968A2 (es) | Nuevos derivados de metilquinazolinona | |
| AR047531A1 (es) | Derivados 1h-tieno(2,3-c)pirazol utiles como inhibidores de quinasa | |
| AR110753A1 (es) | Inhibidores selectivos de jak1 | |
| CU20210016A7 (es) | Dioxociclobutenilamino-3-hidroxi-picolinamidas n-sustituidas útiles como inhibidores de ccr6 | |
| PE20181017A1 (es) | Compuestos heteroarilo y su uso como farmacos terapeuticos | |
| AR091490A1 (es) | Antagonistas de iap | |
| AR118729A1 (es) | Inhibidor selectivo de la jak1 quinasa | |
| UY38892A (es) | Moduladores de sting (estimulador de genes de interferón) | |
| UY26564A1 (es) | Inhibidores del factor xa con aril - amidinas y sus derivados, y composiciones farmacéuticas que contienen los mismos | |
| PE20212327A1 (es) | Ciertos compuestos de pladienolida y metodos de uso | |
| PH12020552186A1 (en) | Cyanotriazole compounds and uses thereof | |
| ECSP20066271A (es) | Derivados de pirazo-tetrahidroisoquinolina como moduladores positivos del receptor de dopamina d1 | |
| DOP2019000299A (es) | Compuestos bicíclicos 5,6-fusionados y composiciones para el tratamiento de enfermedades parasitarias | |
| PE20212333A1 (es) | Compuestos de acido ascorbico y quinona en combinacion con un agente antiparasitario para el tratamiento de una enfermedad parasitaria | |
| CO2023006912A2 (es) | Nuevos derivados de indazol acetileno | |
| UY39308A (es) | Derivados de aminopirimidinilo | |
| CO2023004420A2 (es) | Compuestos heterocíclicos como inhibidores del bromodominio cbp/ep300 |